CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in NUVB — Nuvation Bio Inc.
CIK 884546
SAN FRANCISCO, CA
Position in NUVB
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,547,614
-$9,521,847 QoQ
Shares Held
1,992,451
-1.2% QoQ
Ownership
0.572%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. NUVB ranks #101 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in NUVB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,547,614 | 1,992,451 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $18,069,461 | 2,016,681 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $7,605,331 | 2,055,495 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $4,155,253 | 2,130,899 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,351,288 | 1,904,141 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $5,176,314 | 1,945,983 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,192,294 | 1,394,015 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,893,601 | 1,333,425 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,178,818 | 1,148,027 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,701,261 | 1,126,663 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,396,485 | 1,042,153 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,871,622 | 1,039,790 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,583,309 | 953,801 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,705,201 | 888,126 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,156,544 | 962,743 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,670,359 | 824,185 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $4,949,854 | 941,037 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,715,220 | 907,673 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $6,912,454 | 695,418 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $3,514,860 | 377,536 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,087,389 | 295,444 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||